ChemoCentryx (CCXI) Financials

$628.6 M

Mkt cap, 25-May-2018

$9.5 M

Revenue Q1, 2018
Net income (Q1, 2018)-9.4 M
EBIT (Q1, 2018)-9.9 M
Cash, 31-Mar-201830.6 M
EV602.8 M

Revenue/Financials

Income Statement

Annual

USDFY, 2016FY, 2017

Revenue

11.9 m82.5 m

R&D expense

37.9 m49.5 m

General and administrative expense

14.7 m16.5 m

Operating expense total

52.7 m66 m

EBIT

(40.7 m)16.5 m

EBIT margin, %

(341%)20%

Interest expense

24 k4 k

Interest income

757 k1.4 m

Net Income

(40 m)17.9 m

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018

Revenue

2.8 m4.3 m8.2 m9 m9.5 m

R&D expense

9 m7.5 m8.4 m8.6 m7.9 m11.2 m9.1 m8.4 m10 m14.7 m

General and administrative expense

3.4 m3.5 m3.7 m3.6 m3.8 m4.1 m3.9 m3.2 m4.6 m4.7 m

Operating expense total

12.4 m11.1 m12.1 m12.2 m11.7 m15.3 m12.9 m11.6 m14.5 m15.9 m19.4 m

EBIT

(12.4 m)(11.1 m)(12.1 m)(12.2 m)(11.7 m)(15.3 m)(10.1 m)(7.3 m)(6.3 m)(6.9 m)(9.9 m)

EBIT margin, %

(363%)(172%)(77%)(77%)(103%)

Interest expense

6 k4 k11 k6 k4 k174 k

Interest income

129 k116 k103 k100 k95 k86 k161 k259 k317 k350 k613 k

Net Income

(12.3 m)(10.9 m)(12 m)(12.1 m)(11.6 m)(15.2 m)(10 m)(7.1 m)(6 m)(6.6 m)(9.4 m)

Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

10.3 m16.1 m12.8 m12 m40 m

Accounts Receivable

30.2 m51.1 m

Inventories

596 k972 k757 k722 k

Current Assets

134.3 m74.3 m72 m148.7 m179.8 m

PP&E

1.4 m1.2 m949 k905 k1.2 m

Total Assets

152.4 m117 m78.2 m155.9 m189.3 m

Accounts Payable

909 k748 k675 k671 k1.4 m

Short-term debt

Current Liabilities

6.9 m8.2 m5.5 m38.3 m32.9 m

Long-term debt

4.7 m

Total Debt

4.7 m

Total Liabilities

106 m110.1 m

Additional Paid-in Capital

318.1 m328.4 m339.6 m357 m368.6 m

Retained Earnings

(172.9 m)(219.8 m)(267.1 m)(307.1 m)(289.2 m)

Total Equity

145.3 m108.6 m72.5 m49.9 m79.3 m

Financial Leverage

1 x1.1 x1.1 x3.1 x2.4 x

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018

Cash

13.1 m20.9 m25.4 m11.6 m14.6 m13.4 m21.9 m13.9 m19 m18 m30.6 m

Accounts Receivable

175 k120 k30.2 m530 k1.7 m

Inventories

1.3 m

Current Assets

100.8 m86.1 m76.1 m71.4 m74.2 m65.2 m127 m122.7 m119.9 m122.4 m149.8 m

PP&E

1.2 m1.2 m1.2 m1.1 m1 m925 k858 k778 k984 k1.1 m

Total Assets

135.5 m126.8 m107.3 m96.3 m87.2 m67.4 m142.3 m133.7 m152.4 m127.9 m181.8 m

Accounts Payable

690 k1 m809 k1 m615 k1.3 m513 k840 k819 k1.4 m449 k

Current Liabilities

7.9 m8.1 m7.7 m5.2 m5.5 m7.4 m23 m26.2 m42.5 m44.4 m76.6 m

Long-term debt

4.7 m

Total Debt

4.7 m

Total Liabilities

90.7 m156.2 m

Additional Paid-in Capital

324 m326.1 m331.2 m334.7 m336.9 m342.1 m351.7 m353.7 m359.4 m366.2 m371.7 m

Retained Earnings

(196.7 m)(207.6 m)(231.8 m)(243.9 m)(255.5 m)(282.3 m)(292.3 m)(299.4 m)(313.1 m)(328.9 m)(345.9 m)

Total Equity

127.4 m118.5 m99.4 m90.9 m81.5 m59.8 m59.5 m54.4 m46.3 m37.3 m25.5 m

Financial Leverage

1.1 x1.1 x1.1 x1.1 x1.1 x1.1 x2.4 x2.5 x3.3 x3.4 x7.1 x

Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(38.7 m)(46.9 m)(47.3 m)(40 m)17.9 m

Depreciation and Amortization

576 k543 k477 k348 k418 k

Accounts Receivable

(30.2 m)(20.9 m)

Inventories

Accounts Payable

159 k(161 k)(73 k)(4 k)729 k

Cash From Operating Activities

(33.3 m)(34.3 m)(39.3 m)39.1 m4.9 m

Purchases of PP&E

(723 k)

Cash From Investing Activities

(31.7 m)38.3 m33.9 m(48.8 m)15.6 m

Cash From Financing Activities

66.8 m1.8 m2.2 m8.8 m7.5 m

Interest Paid

26 k137 k137 k137 k

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018

Net Income

(12.3 m)(10.9 m)(12 m)(12.1 m)(11.6 m)(15.2 m)(10 m)(7.1 m)(6 m)(6.6 m)(9.4 m)

Depreciation and Amortization

111 k

Accounts Receivable

175 k120 k30.2 m530 k49.4 m

Inventories

1.3 m

Accounts Payable

690 k1 m809 k1 m615 k1.3 m513 k840 k819 k1.4 m(951 k)

Cash From Operating Activities

40.9 m

Purchases of PP&E

(32 k)

Cash From Investing Activities

(51.1 m)

Cash From Financing Activities

655 k

Ratios

USDY, 2018

EV/EBIT

-61.2 x

EV/CFO

14.7 x

Financial Leverage

7.1 x
Report incorrect company information